A novel group of small non-coding RNA, known as microRNA (miRNA) is predicted to regulate as high as 90% of the coding genes in human. The diversity and abundance of miRNA targets offer an enormous level of combinatorial possibilities and suggest that miRNAs and their targets form a complex regulatory network. In the present study, we analyzed 711 miRNAs and their 34, 525 predicted targets in the miRBase database (http://microrna.sanger.ac.uk/, version 10 ), which generate a complex bipartite network having numerous numbers of genes forming the hub. Genes at the hub (total 9877) are significantly over represented in genes with specific molecular functions, biological processes and biological pathways as revealed from the analysis using PANTHER (http://www.pantherdb.org/genes/). We further construct a miRNA co-target network by linking every pair of miRNAs which co-target at least one gene. The weight of the link, which is taken to be the number of co-targets of the pair of miRNAs vary widely, and we could erase several links while keeping the relevant features of the network intact. The largest connected sub-graph, thus obtained, contains 479 miRNAs. More than 75% of the miRNAs deregulated in 15 different diseases collected from published data are found to be in this largest sub graph. We further analyze this sub-graph to obtain 70 small clusters containing total 330 miRNAs of 479. We identified the biological pathways where the co-targeted genes in the clusters are significantly over-represented in comparison to that obtained with that are not co-targeted by the miRNAs in the cluster. Using published data, we identified that specific clusters of miRNAs are associated with specific diseases by altering particular pathways. We propose that instead of single miRNA, clusters of miRNA that co-targets the genes are important for the regulation of miRNA in diseases.
I. INTRODUCTION
Micro-RNA (miRNA) belongs to a class of small non-coding single stranded RNA, approximately 21 nucleotides long, which negatively regulate gene expressions. Mature miRNA interacts with the 3 ′ untranslated regions (3 ′ UTR) of the gene in human and down regulate the expression of the target either by degrading the mRNA or inhibiting the translation. In some cases, increased expressions of the target gene by miRNAs have also been reported (reviewed in [1] ). Recent experiments show, at least in few specific cases, that the mature miRNA can alters the expressions of the genes by binding to the coding regions as well as 5 ′ UTR of genes [2] [3] [4] providing further complex regulation of the genes by miRNAs. It has been proposed on the basis of theoretical analysis that as many as 30% of genes in the human genome may be the target of miRNA [5] . Recent, estimates predict that as large as 90% human genes are targets of miRNA [6] . However, experimental validation of such prediction is largely lacking. Function of each region of the mature miRNA is not well defined, although, the seed region (2 nd to 7 th position from the 5 ′ end of the mature miRNA), is the most important region * E-mail address: nitaipada.bhattacharya@saha.ac.in † E-mail address: pk.mohanty@saha.ac.in that interacts with 3 ′ UTR for regulation of the target genes. The other regions known as extended seed and delta seed regions also contribute to the target selection [7] . The diversity and abundance of miRNA targets offer an enormous level of combinatorial possibilities and suggest that miRNAs and their targets appear to form a complex regulatory network.
Functions of miRNA is known only for some, although deregulation of miRNAs has been shown in number of diseases like various types of cancers [8, reviewed in 9] cardiovascular development and heart failure [10] . Involvement of miRNAs in various diseases has been recently reviewed [11] . Studies of various diseases and normal cellular processes indicate that miRNAs are involved in immune-system [12] ; stem cell renewal and development [13, 14] . Using inhibitors of different miRNAs it has also been shown that several miRNAs are involved in cell death, cell growth and proliferation [15] . The extent of modulation of the targets and their influences on the biological processes that lead to alteration of cellular phenotype varies considerably [16] . In a recent study in Caenorhabiditis elegans (C. elegans) where 83% of the C. elegans miRNA (total 95 miRNA) are mutated and effects of these mutant genes are studied. It is shown that majority of miRNA mutations do not result into any phenotypic changes, indicating that there are redundancies of miRNAs that can target a gene. However, 10% of miRNA deletion causes clear developmental and morphological defects. It has been proposed that there is signif-icant functional redundancy among miRNAs or among gene pathways regulated by miRNAs [17] . In spite of considerable information on the involvement of miRNA in numerous biological processes and large number of human diseases, the precise information of the targets they regulate in the normal processes and diseases remains elusive.
Role of miRNAs in signal transduction pathway has been identified in a recent work. By analyzing the interactions between miRNAs and a human cellular signaling network, it has been observed that miRNAs specifically target positive regulatory motifs, downstream network components and the highly connected scaffolds in a signaling network and genes whose promoter regions include a large number of putative transcription factor(TF) binding sites [18] . Combinatorial regulation of genes by TF and miRNAs provides higher complex programs [19] . However, it is not known fully how miRNA-miRNA interactions regulates the expressions of the genes. Interactions of miRNA-miRNA and miRNA-TF in regulating the expressions of protein coding genes have recently been studied. Two databases namely Target Scan and PicTar have been used that cataloged 8672 predicted targets of 138 miRNA and 9152 predicted targets of 178 miRNA respectively. There are overlaps ( 80%) in the miRNA lists and targets covered in these two databases [20] . Abilities of three miRNA namely miR-16, miR34a, miR-106b to alter cell cycle, target expressions and apoptosis have been studied. It has been observed that miR-16 and miR-34a together block G1 to S transition greater than that obtained individually but lesser than additive. On the contrary, expression of miR-106b, which accelerates G1 to S transition, together with miR-16 or miR-34a, reduce the cells in G1 less than that obtained with miR-16 or miR-34a alone but higher that obtained with miR-106b alone. This result shows that miR-16 and miR-34a together exhibit an intermediate cellular phenotype. All these miRNAs alter specific sets of the targets. Thus different miRNA may target the different proteins in the same pathways [21] . Experimental evidence also has been provided recently to show that specific pairs of miRNAS together involves in the maintenance of embryonic stem cells [22] . It is important to know whether miRNAs interact in a combinatorial fashion, alters specific biological pathway(s) and participates in human diseases.
In the present communication, using 711 miRNA in human and their predicted targets we have performed a topological analysis of miRNA network to elucidate how miRNA-miRNA interactions regulate the targets. We observe that the miRNA are clustered and that some clusters of miRNA co-target the genes in the specific pathways. Analysis of published experimental data describing deregulated miRNA and mRNA in 15 diseases, support this notion. 
II. RESULTS AND DISCUSSIONS
A. Connectivity in miRNA-gene interaction network
For the analysis of miRNA and their targets in human, we use the miRBase database, (http://microrna.sanger.ac.uk/) which has M = 711 microRNAs (miRNAs) and N = 34525 gene targets. First, a data set is created where the gene versus the set of miRNAs targeting that particular gene is listed row-wise. A schematic representation of the data set as a bi-partite network is shown in Figure 1 . The blue and red circles there represent the miRNAs and the genes respectively. For convenience, both miRNAs and genes are given arbitrary identification number m = 1, 2, . . . i, . . . M and n = 1, 2, . . . j, . . . N respectively. A line (or link) is drawn between micro RNA i and a gene j, if i targets j. In total there are 676265 links which connect the miRNAs and their targets. From the figure it is evident that the system of miRNA-gene form a bi-partite network represented by a (M × N ) adjacency matrix A with matrix elements,
The network is bi-partite, because there is no link between two elements within the group of genes or miRNAs, i.e. two genes or two miRNAs are never connected. In Figure 2A , we have shown the distribution of targets (genes) P g (n), which is the fraction of genes (shown as circles in Figure 1 ) targeted by n number of miRNAs. If the connections had been random (i.e., if 676265 links were distributed among 711 miRNAs randomly) we would have obtained a normal distribution (blue solid line in Figure 2A ). It is clear that P g (n) varies significantly from what is expected from a random bi-partite graph. P g (n) could be fitted to an exponential distribution (shown in the inset of Figure 2A ) with a a typical scale k * = 20. This implies that, most of the genes are targeted by only k < 20 miRNAs. Only a few genes are targeted by a large number (k ≥ 20) of miRNAs which are termed as the target hubs. The degree distribution, being different from a random normal graph, implies that there is a high organizational structure in the gene-miRNA interaction network. Similar organizational structure is observed from the distribution of miRNAs P m (k), which is the fraction of miRNAs that target k number of genes. We find that 126 miRNA in the miRNA hub target ≥ 1067 genes (data not shown). Analysis of the genes in the target hub (total 9877, Suplimentary table S1A) by PANTHER revealed that genes with molecular functions like nucleotide binding, transcription factor, receptor and hydrolase are enriched compared with the genes in the human genome. Genes involved in biological process like apoptosis, cell cycle, developmental process, nucleic acid metabolism, signal transduction etc. are significantly over represented among the genes in the target hub. Genes involved in cell proliferation and differentiation, cell structure and motility and oncogenesis are also significantly decreased. Genes in the target hub are enriched in specific pathways like p53 pathway, angiogenesis, in two neurodegenerative disease pathways namely Alzheimers disease and Huntingtons disease pathway. Representative result of pathways enrichment is shown in the Figure 2B and the full analysis is shown in the Supplementary table S1B to S1D. Results shown in Supplementary table S1B to S1D and in the Figure 2B indicate that miRNA in combination may alter molecular functions, biological processes and cellular pathways. This result is similar to that have been obtained with lesser number of miRNA (about 180) that target approximately 10000 genes [20] .
B. Micro RNA co-target network
To probe the detailed structure of the network, we create a co-target network of miRNA-miRNA as follows : if two miRNA co-target w (non-zero) number of genes, we define that these miRNAs are linked. The weight of the link is w. Otherwise, if w = 0, no connection is made between these miRNAs. By doing so, we form an undirected weighted network of miRNAs. The corresponding adjacent matrix C is symmetric having elements C ij , where C ij is the number of genes co-targeted by miRNA i and j.
. . .
The diagonal elements C ii , are not well defined. We take C ii = 0. Schematic description of this network is shown in the Figure 2C . Few properties of this co-target network can be checked easily. First, it is a "fully connected network", which does not have any sub-graph. The distribution of weights P g (w) is shown in Figure 2D , which is again compared with corresponding random graph. The result indicates that the connections are not random and the network is highly organized. Again we find that there is a huge difference between the maximum wight (C ij ) max = 1253 and the minimum (C ij ) min = 1, which leads to a conjecture that most links might be irrelevant and can be erased. Next, we describe how to get an optimal set of miRNAs, by erasing irrelevant links, which could still describe all essential features of the co-target network.
We define that the weak links are those whose weights are smaller than a pre-decided cutoff q, and erase them. (For example when q = 10, links between (1, 6) and (710, 3) in Figure 2C are to be erased.) The network do not remain fully connected anymore and breaks up into smaller disconnected sub-graphs. Let the number of these disconnected sub graphs be N q , which explicitly depends on q. The largest among these subgraphs, named as G, is the important sub-graph. Clearly size of G decreases with increase of q. For very large q, G has only fewer miRNAs; that might simply the study of this network at the cost that some of the functionalities which are lost. Thus we need to optimize q such that all irrelevant links are erased, keeping only the optimal set of miRNAs in G which are functionally relevent. Note, that the cut-off q redefines a new adjacency matrix
Thus, the number of subgraphs N q is the number of diagonal blocks of C q , which can be found by blockdiagonalizing the matrix C q . Since it is a fully connected graph, initially N 1 = 1 and then N q increases with q. Figure 2D shows a plot of N q versus q.
It is evident from Figure 2D that there are three regimes, (a) q < q * , (b) q ∼ q * and (c) q > q * . Almost all the connections are present in regime (a). In this regime the connections are quite stiff and the network does not break up until a threshold q = q * is reached. By increasing q one goes to regime (b) where the irrelevant connections are already erased and only the relevant connections are present. Thus any little change in q changes N q substantially. The relevant miRNAs, which cooperatively regulate the expressions of the genes to form the co-target network are probably found in regime (b). In regime (c), q is very large to erase even the relevant connections. Only connections which are present in this regime (c) are possibly due to chemical similarity, i.e, the miRNAs form very small subgroups and seed sequences (position 2 to 7 in the mature miRNA) of miRNAs within a subgroup are identical. This proposition has been verified as follows: we take q = 600 and find all the disconnected sub-graphs which have two or more miRNAs. The seed sequence of miRNAs in every sub-group has been checked. We find that the set of miRNAs in each subgroup (except only one of 63 subgroups) have identical seed region [see supplementary table S2 ].
Note that the continuous break-up transition is a distinct property of miRNA co-target network, it does not occur for a random graph as shown in Figure 2D (blue line). To emphasize this point further let us construct a random undirected graph R which has total weight W is same as that of C, i.e.,
Effectively, we need to choose M (M − 1)/2 = 252050 random integers, one for each upper diagonal element of C ( total M (M − 1)/2) so that their sum is W . Since the random matrix R has to be symmetric (R ij = R ji ), the lower diagonal elements can be calculated by substituting R ij by R ji . In a similar way, by varying the cut-off q we find N q for R, which is shown in Figure 2D (as blue dashed line). Note that the break up of the random network into subgraphs in this case occurs discontinuously, unlike the miRNA co-target network. This result indicates that miRNA co-target network is structurally rich. Details topological structure of the network are now being studied. The analysis reveals that the optimally connected graph (the sub-graph having maximum number of relevant miRNA nodes) which still posses the properties of the network can be found if we work at q = q * . To find q * , we differentiate q numerically with respect to q. The maximum of d dq N q (as shown in the Figure 2D ) corresponds to q * = 103. In this case, at q * = 103, N q = 166 and the largest connected sub graph G is found to contain only 479 nodes (for full list of miRNAs in 166 sub graphs see the supplementary table S3). Thus, these nodes or miRNAs form the optimal set of miRNA which co-regulate the gene expressions. To determined how miRNAs are organized within the sub graph G, we increase the cutoff q beyond q * and follow how G as breaks up into smaller clusters of miRNAs. Clusters in this context are defined as the subgraph which has more than one miRNAs. It is expected from Figure 2D that number of such clusters would not change much once we reach region (c) where d dq N q ≃ 0 which starts approximately at q ≈ 160. Thus, we take q = 160 and collect the clusters (the sub graphs of S which have two or more miRNAs). There are in total 70 such clusters containing 330 miRNAs. Thus it is reasonable to assume that the miRNAs within G are organized as 70 clusters, 169 independent miRNAs and interactions between them. These clusters form the basic units of the miRNA interaction network. Figure 3 shows the interaction network of miRNA of 70 clusters. In the present study, we clustered the miRNAs on the basis of their ability to co-target the same genes, however, such co-targeting could be due to similarity in the seed sequences. We checked that 18 out of 70 clusters might be due to seed similarity. About 50% of the miRNA in human are organized within 10Kb of genomic Nq (which is scaled by a factor 20 for better visibility) shows a peak at q * = 103.
sequence. Whether organizationally clustered miRNAs are under same regulatory sequence and expressed together remains unknown. Eleven out of 70 clusters might be due to the genomic organization (Supplementary table  S4) . We extended our analysis to study miRNAmiRNA interaction networks in Caenorhabditis elegans with 136 miRNAs and their 20366 targets (http://microrna.sanger.ac.uk/cgi-bin/targets/v5/genome.pl). The optimal value of q in this network is q * = 23. The largest connected sub graph at q = q * contains 98 miRNAs. Most surprisingly, we find that both the species show universal features near the breakdown transition, similar to that shown for human in Figure 2D (data not shown). Reasons for such similarity in break down of miRNA-miRNA interaction network require further studies.
It is also interesting to note that the clusters of miRNAs form a interaction network through their common targets (shown in Figure 3 and discussed in section 4.4). Biological significance of this network in under investigation.
C. Co-targeted genes in miRNA clusters may involve in specific pathways
We need to know the biological relevance of the miRNA clusters better as they form the basic units of biological interactions for the regulation of the targets. The smallest cluster in subgraph S, of course, contains two miRNAs, while the largest cluster contains 47 miRNAs (Supplementary table S4 ). To explore whether the miRNAs in clusters target genes in specific pathways we determine if the co-targeted genes in a miRNA cluster is involved in any specific pathway. To do so, we determine the common targets of the miRNAs in a cluster taking two miRNA at a time, and then asked whether the co-targeted genes are enriched for a particular pathway(s) compared to the targets which are not co-targeted by the miRNA in that cluster. For example, there are three miRNAs in cluster no. 25 (supplementary table S4), namely miR-603, miR-521 and miR-523, which do not have common seed sequence and in combination [miR-603 and miR-521 (n 1 ) and miR-521 and miR-523 (n 2 ) and mir-523 and miR-603 (n 3 )] target 449 genes [(n 1 + n 2 + n 3 )]. These three miRNAs together target 2309 genes. The number of genes not targeted by the miRNAs in this cluster is 1860. Using the PANTHER, we observed that common targeted genes (449) are significantly (p ≤ 0.05) enriched in axon guidance mediated by semamorphins (P00007), cell cycle (P00013), DNA replication (P00017) and FGF signaling (P00021) pathways. This analysis further reveals that out of 70 clusters, cotargeted genes in 47 clusters are significantly enriched at least one biological pathway (total biological pathways in human at PANTHER database is 153). In several cases, the co-targeted genes are over represented in more than one pathway (supplementary table S4 ). Significant enhancement of the genes co-targeted by the miRNAs in a cluster indicate that these clustered miRNAs regulate genes in specific pathway.
D. Involvement of clustered miRNAs in human diseases
Alterations of several miRNAs have been observed experimentally in about eighty diseases [25] . To probe whether the clustered miRNAs obtained above are associated with any disease, we retrieved data from published papers, where deregulated miRNAs in diseases are reported. We collected data for 15 diseases where dereg-ulation of miRNAs are reported (Supplementary table  S5 (Supplementary table S5) . We note that total number of miRNAs studied in these reports are not available for all the cases, making it difficult to assign the miRNAs which are not changed in these diseases. Among the altered miRNAs, number of miRNAs in the largest cluster G (479 miRNA) with q=103, and in the 70 clusters (S) derived from the G with q = 160 is shown in the TABLE I. It is evident from the table that for some diseases, the numbers of miRNAs in G are significantly higher than one expects from random distributions of the miRNAs in clusters. For example, in prostate cancer, 48 miRNAs are deregulated, out of which 41 miRNAs belong to the cluster G (479 miRNA). The expected number of miRNA in this cluster is 32 (479 × 48/711), which is significantly lower from the observed value of 41 miRNA. It is interesting to note that when the largest cluster G was broken into 70 inter-connected clusters (S), the level of significances of the miRNAs among 70 clusters than the expected values (shown in TABLE I) are increased considerably. This trend further justified the breaking of the largest cluster/sub-graph G into smaller ones.
The miRNAs deregulated in the diseases are distributed among the 70 clusters in S and compared with that was expected from random distributions. For example, out of 28 miRNA deregulated in breast cancer, 18 miRNAs are distributed in 11 clusters (cluster # 3, 16, 20, 35, 37, 51, 57, 63, 64, 67 and 68, as shown in the supplementary table S4) among the 70 clusters. Among these 11 clusters, where 18 deregulated miRNAs are distributed, 8 clusters (cluster # 3, 16, 20, 35, 37, 51, 57 and 64, see supplementary table S4 for the clusters) have significantly higher number of miRNA than that one expects from random distribution. Similarly, out of 22 miRNA deregulated in schizophrenia 18 miRNA in S are distributed in 11 clusters. Among these 11 clusters only 8 clusters have significantly higher number of miRNA than one expects. Distributions of miRNAs in different clusters are significantly different from that expected from random distributions. The representative result is shown in the Figure 4 and the detailed result for all these 15 diseases are shown in the supplementary Figure SF1 . This result shows that significant numbers of deregulated miRNAs in the diseases studied in this investigation belong to specific clusters. Only the clusters, which harbor significantly higher number of miRNA over the random distributions, are considered for further analysis (see next section). Common targeted genes in different clusters are significantly enriched in different pathways as shown in the earlier section above. CLL (1967) and glioblastoma (6528) was taken from ONCOMINE (http://www.oncomine.org/) and determined whether deregulated genes are enriched in specific pathway(s). Detailed result is shown in the supplementary table S6. It is to be noted that only a subset of these deregulated genes are likely to be deregulated by miRNAs. We compared the pathways that are enriched for the deregulated genes in comparison to that obtained among genes coded by human genom. in microarray data with that are obtained for deregulated miRNAs in these diseases and significantly enriched in the clusters as described above. As mentioned above, in breast cancer, 28 miRNAs are deregulated; 18 miRNA We then compared the pathways that are enriched for the deregulated genes and observed that 10 unique pathways are common. Common pathways that are enriched in the specific clusters of miRNAs and deregulated genes in diseases further indicate that the specific clusters of miRNA are likely to target specific pathway(s) and involve in diseases. together 330 miRNA and each cluster contains has than 2 miRNA. Out of these 70 clusters, 18 clusters could arise due to the seed similarities and 11 clusters could arise for genomic organization (co-localized). Among these clusters, 4 clusters are common for the seed similarity and co-localization (Supplementary table S4) . It is interesting to note that out of 18 clusters, which could arise due to seed sequence similarity, only 5 clusters are associated with pathways, which are enriched with cotargeted genes. Two clusters (#26 and #31) that could arise from seed sequence similarity and co localization, also associated with co-targeted genes enriched in spe-cific pathways. This result indicates that in the majority of cases, clustered miRNA did not arise due to seed sequence similarity. Co-targeted genes in the miRNA cluster and enriched in specific pathways for 5 clusters could arise from co-localization of the miRNAs in the genomic regions. These miRNAs, which are co localized in the same chromosomal region (with in 10Kb upstream and down stream of the pre-miRNA) might be regulated by the same promoter regions and co-expressed together. In a recent study, miRNAs hsa-mir-92a-1,hsamir-20a, hsa-mir-18a,hsa-mir-17,hsa-mir-19b-1 and hsamir-19a, which are co localized on chromosome 13 within 10kb, have been shown to act in a combinatorial fashion. The authors explained that in combination, the miRNA down regulated to the measurable extent, while individual miRNA was unable to down regulate the target sufficiently [21] . This result also support the notion that miRNAs in combination lowers the expressions than an individual miRNA. In the majority (47/70) of the miRNA clusters, co-targeted genes are enriched in at least one pathway. Out of 153 pathways described in the PAN-THER (total number of genes 25431, total number pathway hit in 7151, thus one gene is involved in more than one pathways), 105 distinct pathways are enriched with the co-targeted genes in 47 clusters. Among these 47 clusters, 28 clusters contain significantly excess deregulated miRNAs in diseases. Co-targeted genes in these 28 clusters are enriched in 72 distinct pathways. Same pathway appeared in multiple times in different diseases, altogether 72 pathways appeared 359 times in diseases. For example, Huntingtons disease pathway (P00029) appears 19 times in 15 diseases indicating the importance of this pathway in several diseases. The miRNA clusters where co-targeted genes are enriched in this particular pathway and also harbors significantly higher deregulated miRNA in diseases are 4 (423-3p, miR-24), 33 (miR-149, miR-892b), 52 (miR-508-5p, miR-516a-3p, miR-198, miR-520a-5p, miR-517*, miR-525-5p, miR-516b, miR518c*, miR-518e*, miR-518d-5p, miR-518f*), 55 (miR-373*, miR-616*, miR-888), 64 (miR-331-3p, miR-146b-3p, miR-18b*, miR-18a*, miR-324-5p, miR-874, miR-324-3p, miR-10a, miR-10b). These miRNAs are likely to target 172 genes in Huntington disease pathway and participates in the diseases discussed in this manuscript. It is interesting to mention, although significance if any remains unknown, that Huntingtons disease pathway was also over represented among the genes at the target hub as described in earlier section. Experimental verification to substantiate of the contention that miRNAs in the clusters together alter this pathway is necessary to confirm the prediction.
III. CONCLUSION
In conclusion, we constructed a miRNA-miRNA weighted interaction network using 711 miRNAs and their predicted targets. A novel method was applied to break up the network into smaller sub graphs (clusters). We further extended our studies to show that specific clusters of miRNA might be involved in specific pathways that are known/predicted in several diseases. We propose that instead of a single miRNA, a group of miRNA together target genes in specific pathway and the interactions of these clusters are likely to be involved in diseases.
IV. METHOD A. Data mining
All the miRNA and the predicted targets are downloaded from miRBase (http://microrna.sanger.ac.uk/, version 10). In version 10 of this database, there are 711 miRNAs coded by 533 genomic loci. This is because, double stranded miRNA produced by DICER and other protein is separated by helicase, and in some cases both the strands can act as the mature single stranded miRNA. In general, the expression of one of the strand is more than the others. The strand, which expresses less, is denoted by mir*. Predicted numbers of transcript (mRNA) that are targeted by this 711 miRNA is 34525. It is to be noted that total number of human genes in PANTHER is 25431. Thus, it is likely that the some of the targets of miRNA in the Sanger database may actually be the isoform of the genes. All the predicted targets of miRNA in miRBase are identified with the ENSEM-BLE ID (http://www.ensembl.org/). For analysis with different data bases, the IDs are converted into NCBI gene IDs by using the site Clone/Gene Id Converter (http://idconverter.bioinfo.cnio.es/) and Ensemble Genome Browser (http://www.ensembl.org/index.html).
Genes which are down regulated or up regulated in various cancers are downloaded from ONCOMINE (http://www.oncomine.org/). For other diseases, we collected the deregulated genes from various published data. ONCOMINE provides the gene names/symbols. These gene names are converted into the NCBI gene Id (NM numbers) by using the site Clone/Gene Id Converter (http://idconverter.bioinfo.cnio.es/) and by using various web sites as mentioned above. The deregulated miRNAs in different diseases are also collected from the different published data. Full references are provided in the supplementary text.
B. Formation of network
We use in house perl scripts to convert the dataset containing 711 miRNAs and their targets into adjacency matrix A ij (see text) by giving arbitrary, but unique, identification numbers to genes as i = 1, 2 . . . N and miRNAs as j = 1, 2 . . . M respectively. A ij may take value 1 if gene i contains a predicted recognition site for miRNA j in the 3 ′ UTR or otherwise A ij = 0. Corresponding network is shown in Figure 1 , where all the genes (miRNAs) are represented as red(blue) circles and a line (joining blue circle j red circlei) is drawn if A ij = 1.
Further, matrix A is used for constructing a miRNA co-target network. Two miRNAs j and k are said to be connected if they have at least one common target. Weight of the connection or link is defined to be C jk , which is simply the number of common targets of miRNA j and k. Matrix C has dimesion 711 × 711, which can be constructed from A as C = A T A, where transpose of A is defined as (A T ) ji = A ij . Or in otherwords,
C. Clustering of miRNAs in miRNA co-target network
Since the miRNA co-target network is fully connected with large number of links having very small weights, we would like to get rid of these links and find sub-graph which contains only relevent miRNAs. This can be done by erasing the weak links, say the links which has weight less than a cutoff q. The network, then breaks up into several disconnected sub-graphs, in total N q . Thus, N q is just the number of diagonal blocks of matrix C, which was calculated using an in house C program. N q changes marginally as q is increased and then a rapid change occurs at q = q * . It is assumed that the network breaks rapidly as the relevent (or most significant) links are removed. To find q * , we differentiate N q with respect to q numerically and find the peak position, which corresponds to the q value where the change is maximum. Now we fix q = q * and find the largest sub-graph G among N q * subgraphs. G is considered to be the relevant. To know, how the miRNAs are arranged within G we further increase q to 160 (see text for the explanation on why we choose q = 160) and collect the subgraphs of G. The sub-graph G containing more than one miRNA are called clusters.
D. Network of miRNA clusters
To get a network of miRNA clusters, first we get the weight W mn of the link between cluster m and n. Let cluster m (n) has N m ( N n ) miRNAs. We add the weights(no of co-targets) of every pair miRNA, fromed by taking one miRNA from cluster m and the other from cluster n, and define the sum to be the weight of the link. Thus, W forms a (70 × 70) matrix with elements
The diagonal elements W nn are non-zero and it indicates the strength of the cluster which is the total number of pair-wise co-targets of the cluster n. There is no natural cutoff on the weights as they show a scale free distribution (data not shown). We take an arbitrary cutoff 2000 to draw the network, i.e, a link is drawn between cluster m and n only if W mn > 2000.
E. Co-targeted genes in miRNA clusters
For the identification of target genes in a specific cluster, we first find the co-targeted genes pair wise in a cluster. For example, if there are three miRNA like miR-1, miR-2 and miR-3 (hypothetical) are in a cluster, the predicted common targets of the miRNAs are those, which are common for miR-1 and miR-2 (n 1 ), miR-2 and miR-3 (n 2 ), miR-1 and miR-3 (n 3 ). The pathway(s) where these common targets (n = n 1 + n 2 + n 3 ) belong are obtained from the PANTHER. This result was compared with that obtained with those targets, which are not common (m−n in total, where m is the total predicted targets of miR-1, miR-2 and miR-3). In PANTHER (Protein Analysis Through Evolutionary Relationships), genes are classified on the basis of their functions using published experimental observations and evolutionary relationships; in the absence of direct experimental evidence. Proteins are classified by expert biologists and categorized by molecular function and biological process and biological pathways (http://www.pantherdb.org/). In miRNA target search, targets are identified with the Ensemble IDs that contains several isoforms of the genes. We omitted these isoforms as well as other Ensemble IDs for which we are unable to retrieve the Gene symbols for PANTHER analysis. To identify, whether genes in target hub, co-targeted by miRNA in clusters and deregulated in diseases when classified on the basis of molecular functions, biological processes and pathways are over represented (enhanced) in particular category in comparison with that obtained in the human genome we analyzed the genes using the PANTHER. If the fraction of genes in the test samples are significantly enriched in a particular category over that obtained in the human genome, we consider the specific category is involved/associated with the test samples. For example, if the co-targeted genes in a particular cluster are significantly over represented in Wnt signaling pathway (PANTHER ID P00057), we consider that this cluster was associated with this pathway.
Deregulated expressions of genes observed in several diseases discussed in this manuscript which are taken from published literature are analyzed using PANRHER. Significant (p values less than 0.05) increase in genes in specific pathways in comparison with that of the human genom are identified.
G. Correlation of miRNAs in clusters and diseases
From the published literature we collected 15 diseases where the deregulation of several miRNAs are reported. We then ask: what fraction these reported miRNAs, say n in total, are distributed among the 70 different clusters (obtained at q = 160, see text for details). This fraction is then compared with the random distribution of n miRNAs among 70 clusters. Those clusters having miRNAs significantly larger (with p values less than 0.05) than that of a random distribution are considered relevant for this particular disease. Significantly enriched genes in pathways, identified from common miRNA targeted genes in these relevant clusters, are compared with the pathways of significantly enriched genes observed in deregulated mRNAs (from micro-array data).
H. Comparisons of the pathways between those observed in common targeted genes in clusters and that of in deregulated mRNA in diseases
From ONCOMINE and published literature we collected the deregulated genes in 15 diseases and analyzed using PANTHER. Significantly altered pathways are identified. These are then compared with the pathways obtained in common targeted genes in clusters.
I. Statistical analysis
Calculation of p value can be best described with an example. If n = 11 is the number of miRNA present in a cluster among total N = 330 miRNA, and for a particular disease there are only m = 2 miRNAs in that cluster among total M = 30 miRNAs, then χ 2 = (mN/M − n) 2 [1/n + 1/(N − n)], which is 11.38 in this example. p value is the probability that x > χ 2 in chi-square distribution Q(x). Thus, p = 1 − Q(x)dx which can be readily integrated using Mathematica or by reading it from a Table. In this example p = 0.00074. Note that p < .050 is equivalent to χ 2 > 3.841.
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PKM and NPB conceptualized the problems, PKM, SUSHMITA, MS and SM carried out the computational analysis, PKM, SUSHMITA and NPB analyzed the data and wrote the manuscript. Table S1 : List of the genes that targeted by more than 20 miRNAs (target hub) [S1A]. Genes at target hub are classified using PANTHER according to molecular functions, biological processes and biological pathways and compared with that obtained with the human genome (S1 B, S1C and S1D). Table S2 : List of the miRNAs that have same seed regions (position 2 to 7 in the mature miRNA) nucleotides of the the mature miRNAs. Table S3 : List of miRNAs in 166 sub graphs which are found at q * = 103. Table S4 : List of 70 clusters and the miRNAs belonging to each cluster, seed sequence similarity, genomic organization (only those which are clustered together within 10kb genomic region are only noted). In a cluster, the common targets for each pair of miRNA is determined and added. Biological pathways for the common targets in comparisons with the total targets that are not common are compared. Only the pathways that are significantly (less than equal to 0.05) enriched in the targets are shown. Table S5 : Experimentally observed deregulated miRNAs in 15 different diseases are shown. For references of the sources of these miRNA please see the supplementary text. Table S6 : Analysis of deregulated genes in 15 different diseases is shown. For references of the sources of the experimentally determined deregulated genes please see the supplementary text. Table S7 : Significantly enhanced genes in pathways for altered mRNA is listed for 15 different diseases. Those pathways which are common to the pathways predicted from the miRNA clusters are marked (in red).
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Distributions of various experimentally determined deregulated miRNAs among 70 clusters of miRNAs
